<DOC>
	<DOCNO>NCT01594554</DOCNO>
	<brief_summary>A 5-year study observe describe long-term patient management treatment pattern associate outcomes patient previously enrol Protocol AI452009 ( i.e. , CCgenos cross sectional phase , ClinicalTrials.gov Identifier : NCT01293279 ) genotype characterize diagnosis HCV infection real world clinical practice China .</brief_summary>
	<brief_title>A 5-year Observational Follow-up Study Describe Treatment Patterns Real World HCV Patients China .</brief_title>
	<detailed_description>A sample 600 Han ethnic Chinese male female â‰¥ 18 year old enrol complete study AI452-009 ( i.e. , CCgenos cross sectional phase , ClinicalTrials.gov Identifier : NCT01293279 ) . In AI452-009 study , patient recent confirmation anti-HCV-antibody positive HCV RNA positive antiviral treatment naive 28 university affiliate hospital China . The primary objective study ( AI452-018 , CCgenos follow phase , ClinicalTrials.gov Identifier : NCT01293279 ) observe describe long-term patient management treatment pattern associate outcomes patient previously enrol Protocol AI452009 ( i.e. , CCgenos cross sectional phase , ClinicalTrials.gov Identifier : NCT01293279 ) genotype characterize diagnosis HCV infection real world clinical practice China .</detailed_description>
	<mesh_term>Hepatitis C</mesh_term>
	<criteria>None . Patients AI452009 study accept ICF follow &lt; 18 year old Han ethnic Not willing follow 5 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>HCV viral genotype</keyword>
	<keyword>host genotype</keyword>
	<keyword>IL28B</keyword>
	<keyword>Outcome</keyword>
	<keyword>Follow-Up</keyword>
	<keyword>ITPA</keyword>
	<keyword>RNA</keyword>
	<keyword>China</keyword>
</DOC>